Deal Watch: Lilly Looks To Alchemab’s ‘Resilient’ Antibodies To Take On ALS

Plus deals involving Synaffix/Mitsubishi Tanabe/Boehringer Ingelheim, Newron/Myung In, Vividion/Tavros, Novo Nordisk/Variant, Vertex/Orna, Sanofi/Alloy and more.